Baculovirus-based COVID-19 Detection and Vaccine
Updated time: 2023-02-17 15:37:12
Baculovirus-based COVID-19 Detection and Vaccine
Docket Number
13A-1090211
Announcement Date
2020-06-10
IP Status
TW I788809 、U.S. provisional pending
Abstract
The invention uses an insect baculovirus, which is non-infectious to humans, to efficiently produce SARS-CoV-2 antigen proteins. These proteins are displayed on the surface of cells or baculoviruses, and can be used to establish a serum detection platform for COVID-19 and to be a vector vaccine against infection, respectively.
Technological Advantages
- High human safety
- Simple and fast for production, no protein purification needed
- Simultaneous development of testing reagent and vaccine
Applications of Technology
- Anti-serum detection of SARS-CoV-2
- SARS-CoV-2 vaccine development
Inventor
Yu-Chan Chao
Contact person
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office
Download Files

Baculovirus-based COVID-19 Detection and Vaccine